Cancer

Items 1191-1200 of 1388

per page
Set Descending Direction
  1. PARG (human) (rec.) (His) (active) (1µg)
    BBL-2283
    BBL-2283-C0011 µg
    CHF 441.00
    PARG (human) (rec.) (His) (active) (1µg)
  2. Parkin (E3 Ligase) (human) (rec.) (His)
    SBB-CE0055
    SBB-CE0055-C05050 µg
    CHF 557.00
    Parkin (E3 Ligase) (human) (rec.) (His)
  3. Parkin E3 Ligase TR-FRET Kit
    SBB-KF0036
    SBB-KF0036-KI011 Kit
    CHF 1'250.00
    Parkin E3 Ligase TR-FRET Kit
  4. Parthenolide
    CAS  20554-84-1
    AG-CN2-0455
    AG-CN2-0455-M01010 mg
    CHF 35.00
    AG-CN2-0455-M05050 mg
    CHF 80.00
    AG-CN2-0455-M250250 mg
    CHF 240.00
    Parthenolide
  5. PD 98,059
    CAS  167869-21-8
    AG-CR1-0118
    AG-CR1-0118-M0011 mg
    CHF 25.00
    AG-CR1-0118-M0055 mg
    CHF 80.00
    AG-CR1-0118-M01010 mg
    CHF 120.00
    AG-CR1-0118-M05050 mg
    CHF 360.00
    PD 98,059
  6. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  7. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  8. Pepstatin A
    CAS  26305-03-3
    AG-CP3-7001
    AG-CP3-7001-M0055 mg
    CHF 45.00
    AG-CP3-7001-M02525 mg
    CHF 125.00
    AG-CP3-7001-M100100 mg
    CHF 370.00
    Pepstatin A
  9. Periostin (human) (rec.)
    AG-40B-0104
    AG-40B-0104-C01010 µg
    CHF 170.00
    AG-40B-0104-30103 x 10 µg
    CHF 335.00
  10. Periostin (human) ELISA Kit
    AG-45B-0004
    AG-45B-0004-KI0196 wells
    CHF 580.00
    Periostin (human) ELISA Kit

Items 1191-1200 of 1388

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.